Clinical Trials Logo
  1. Home
  2. HIV Positive
  3. NCT03660722

Bone, Inflammation, Gut and Renal Biomarkers in Antiretroviral Naïve HIV-1 Positive Subjects — BIGGER  

HIV Positive Clinical Trial

Official title:
Bone, Inflammation, Gut and Renal Biomarkers in Antiretroviral Naïve HIV-1 Positive Subjects Commencing Antiretroviral Therapy: the BIGgeR Study.

Clinical Trial Summary

Co-morbidities, including low bone mineral density, increased visceral adiposity and chronic kidney disease (CKD) are frequent in people living with HIV, and may be driven by ongoing inflammation and immune activation. Initiation of ART reduces inflammation and immune activation and is associated with changes in bone and renal biomarkers and gut microbiota. Investigators hypothesise that changes in gut microbiome when starting antiretroviral therapy correlate to changes in bone and renal biomarkers and wish to explore possible mechanisms linking these by investigating changes in markers of inflammation and immune activation.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03660722
Study type Interventional
Source Centre Hospitalier Universitaire de Saint Etienne
Contact
Status Withdrawn
Phase N/A
Start date October 2023
Completion date February 2024
View Details
See also
  Status Clinical Trial Phase
Completed NCT00639145 - Elizabeth Glaser Pediatric AIDS Foundation Maternal Events and Pregnancy Outcomes (MEP Project)A Multi-site Protocol
Completed NCT01152684 - Complementary & Alternative Medicine Use in HIV+ Latinos in the US-Mexico Border
Completed NCT01957748 - CCTG 594: Engagement and Retention in Care for HIV+ N/A
Completed NCT01818258 - IMPAACT P1092: Steady State PK in Malnourished HIV Infected Children Phase 4
Completed NCT01793467 - Transplantation and the Use of Raltegravir in HIV-Infected Patients N/A
Completed NCT02938377 - Alcohol Research Consortium in HIV-Intervention Research Arm Phase 4
Completed NCT01898754 - Oligonucleotide Ligation Assay (OLA) Resistance Study N/A
Active, not recruiting NCT01365065 - Safety and Effect on HIV Transcription of Vorinostat in Patients Receiving Suppressive Combination Anti-retroviral Therapy Phase 2
Completed NCT00106795 - Relationship Between Fatigue and Mitochondrial Damage in Patients With HIV/AIDS N/A
Not yet recruiting NCT02404233 - Open Label, Pilot Study of Darunavir Boosted by Cobicistat in Combination With Rilpivirine to Treat HIV+ Naïve Subjects Phase 4
Completed NCT01154543 - Safety and Efficacy of Famciclovir in HIV1 Positive Adults With Recurrent Genital Herpes N/A
Completed NCT01154556 - RETRIeVE: ReversE TranscRiptase Inhibitor hiV Practice N/A
Completed NCT00857350 - The Prevalence of HIV Drug Resistance and Transmission Risk in Opioid Agonist Treatment N/A
Recruiting NCT01875588 - Thinking and Memory Problems in People With HIV
Completed NCT01941121 - CCTG 593: Testing and Linkage to Care N/A
Terminated NCT01904201 - Evaluation of a Blood Test to Measure Immune Function in HIV Positive People Compared With HIV Negative People N/A
Enrolling by invitation NCT00941889 - The Effect of HPV Vaccination on Recurrence Rates in HIV Patients With Condylomata N/A
Completed NCT03531749 - Antioxidant in Patients HIV+ Supplemented With Microencapsulated of Red Pomegranate N/A
Completed NCT02935296 - Integrated Treatment and Prevention for People Who Inject Drugs Phase 3
Completed NCT01536912 - Medical Marijuana Use in HIV+ Patients: Probability Survey N/A